A Phase 1b Study Evaluating Cobimetinib Plus Atezolizumab in Patients with Advanced BRAFv600 Wild Type Melanoma Who Have Progressed During or After Treatment with Anti-PD-1 Therapy and Atezolizumab Monotherapy in Patients with Previoulsy Untreated Advanced BRAFv600 Wild-Type Melanoma.
- Haydon, Andrew (Primary Chief Investigator (PCI))
- Cross, Nikki (Project Manager)
Project: Research